[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351907-105":3,"doc-detail-351907-en":81,"detail-sidebar-cat-0-en-105":115},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","chemoresistance-in-ovarian-cancer-and-association-with-circadian-rhythm","Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm","","Ovarian cancer causes a substantial share of cancer-related deaths among women worldwide. Most cases are epithelial malignancies, and standard care combines platinum-based chemotherapy with surgical treatment. Chemoresistance limits therapy effectiveness through multiple interacting mechanisms, including genetic influences and tumor microenvironment effects, with additional risk-related factors such as obesity. The review connects circadian rhythm regulation to ovarian physiology and explores how circadian disruption may affect chemotherapy resistance, aiming to inform resistance-reducing approaches.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/chemoresistance-in-ovarian-cancer-and-association-with-circadian-rhythm/351907/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/chemoresistance-in-ovarian-cancer-and-association-with-circadian-rhythm/351907.png","ImageObject",300,407,{"name":42,"@type":43},"Ben ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the standard treatment for ovarian malignancies mentioned in the review?","Question",{"text":63,"@type":64},"The review states that preferred treatment consists of platinum-based chemotherapy and surgical intervention.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which factors contribute to chemoresistance in ovarian cancer?",{"text":68,"@type":64},"It highlights multiple contributing pathways, including genetic factors, tumor microenvironment interactions, and lifestyle-related variables such as obesity.",{"name":70,"@type":61,"acceptedAnswer":71},"How does circadian rhythm relate to ovarian function and cancer risk in the article?",{"text":72,"@type":64},"The review explains that circadian rhythm regulates key physiological processes and that circadian genes are highly expressed in the ovaries, while disruption of circadian rhythm is associated with risk factors for ovarian cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351907,1790194199,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":92,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":93,"faqs":94,"seo_title":95,"seo_description":12,"update_tm":96,"read_time":97,"preview_page_count":33,"preview_urls":98},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",8,"Reproductive Sciences (2026) 33:1079–1090  \n[https://doi.org/10.1007/s43032-026-02093-9](https://doi.org/10.1007/s43032-026-02093-9)  \nGYNECOLOGIC ONCOLOGY: REVIEW  \nChemoresistance in Ovarian Cancer and Association with Circadian Rhythm  \nFatma Seher Pektopal1 · Selen Kum Özşengezer1 · Zekiye Sultan Altun1  \nReceived: 19 November 2024 / Accepted: 21 March 2026 / Published online: 4 May 2026 © The Author(s) 2026  \nAbstract  \nOvarian cancer (OC) accounts for a significant percentage of cancer-related deaths in women worldwide. A small proportion of ovarian cancers, usually in women under 40, originate from germ cells and stromal cells within the ovary, but the vast majority are epithelial malignancies. The preferred treatment for ovarian malignancies consists of platinum-based chemotherapy and surgical intervention.  \nChemoresistance in ovarian cancer is a complex problem that significantly impedes tratment efficacy. Many pathways contribute to this resistance, including genetic factors, tumor microenvironment interactions, and lifestyle variables such as obesity. Understanding these mechanisms is crucial for developing effective treatment solutions. The circadian rhythm, or circadian clock, regulates the sleep–wake cycle, body temperature, hormone secretion, metabolism, and many physiological processes. Circadian genes are highly expressed in the ovaries, which regulate ovulation. Disruption of circadian rhythm asociated with many risk factors for ovarian cancer. This article examines the relationship between circadian rhythm and chemotherapy resistance in ovarian cancer, and reviews circadian rhythm to reduce chemotherapy resistance in this context.  \nKeywords Ovarian cancer · Circadian rhythm · Chemoresistance · Cisplatin  \nOvarian Cancer  \nOvarian cancer (OC) is the seventh most prevalent cancer type in women globally and the eighth leading cause of cancer-related deaths. [1, 2] . Although it has higher incidence rates in developed locations, it is noted to have lower rates in less developed countries. In high-income countries, the incidence has shown a declining tendency in recent years, while it has been rising in low-income countries. Consistent with the global trend, most ovarian cancer cases are diagnosed at advanced stages. This complicates tretament procedures and reduces chances for survival. In conclusion, early diagnosis, raising awareness, obesity management, and the promotion of healthy practices such as smoking cessation are crucial in combating this kind of cancer in Turkey. [1, 2] .  \n􀀍 Fatma Seher Pektopal[f.seherpektopal@gmail.com](f.seherpektopal@gmail.com)  \n1 Department of Basic Oncology, Oncology Institute, Dokuz Eylül University, Izmir, Turkey  \nOvarian cancer is a malignancy with various types. A small portion of ovarian malignancies, usually in women under 40 years old, originate from germ cells and stromal cells within the ovary. [3] . A significantly larger proportion consists of epithelial malignancies. This category exhibits genetic and etiological diversity. They are classified into five main histotypes: high-grade serous, low-grade serous, endometrioid, clear cell, and mucinous tumors, each respondes differently to treatment. In addition to these invasive cancers, there are also borderline serous and mucinous neoplasms, that Show high proliferation and atypia compared to benign tumors, but are less distinct than low-grade carcinomas. The predominant histotype originates from serous tubal intraepithelial carcinoma (STIC) lesions found at the fimbrial of the fallopian tubes, whereas endometrioid and clear cell malignancies likely develop in ares of endometriosis [3, 4] .  \nFamilial history is the most important risk factor for ovarian cancer. Hereditary ovarian cancer manifests in three clinical patterns. These include regional ovarian cancer, breast-ovarian cancer syndrome, and hereditary nonpolyposis colorectal cancer (HNPCC; Lynch II) syndrome.  \nThe first two categories are linked to germline","cbCaiiHaipvIPRJy","https://ap.wps.com/l/cbCaiiHaipvIPRJy","pdf",1109342,"English","# Abstract\n# Ovarian Cancer\n## Epidemiology and clinical challenge\n## Histotypes and tumor origin\n# Risk Factors\n## Familial and hereditary patterns\n# Genetic Basis and Next-Generation Sequencing\n## Hereditary tumor gene analysis\n# Chemotherapy Resistance in Ovarian Cancer\n## Platinum-based treatment and resistance mechanisms","[{\"question\":\"What is the standard treatment for ovarian malignancies mentioned in the review?\",\"answer\":\"The review states that preferred treatment consists of platinum-based chemotherapy and surgical intervention.\"},{\"question\":\"Which factors contribute to chemoresistance in ovarian cancer?\",\"answer\":\"It highlights multiple contributing pathways, including genetic factors, tumor microenvironment interactions, and lifestyle-related variables such as obesity.\"},{\"question\":\"How does circadian rhythm relate to ovarian function and cancer risk in the article?\",\"answer\":\"The review explains that circadian rhythm regulates key physiological processes and that circadian genes are highly expressed in the ovaries, while disruption of circadian rhythm is associated with risk factors for ovarian cancer.\"}]","Chemoresistance in Ovarian Cancer and Association with Circadian Rhythm | PDF",1790096477,30,[99,103,107,111],{"page_no":22,"url":100,"width":101,"height":102},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c85cb174edadf59a6ff3bec4c5c697ca.webp",983,1305,{"page_no":26,"url":104,"width":105,"height":106},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ef10dc144081ca44bc72b2f90295610.webp",982,1304,{"page_no":30,"url":108,"width":109,"height":110},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e66b958f717b687a2fdca05c5ab91353.webp",981,1303,{"page_no":33,"url":112,"width":113,"height":114},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b52df1f921b69118f939106d049fdf7f.webp",980,1301,{"code":4,"msg":82,"data":116},[117,121,125,129,134,139,144,146,151,154,158],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":118,"show_sort_weight":119,"slug":120},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":122,"show_sort_weight":123,"slug":124},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":126,"show_sort_weight":127,"slug":128},"Exam",70,"exam",{"id":130,"doc_module":4,"doc_module_name":25,"category_name":131,"show_sort_weight":132,"slug":133},5,"Comic",60,"comic",{"id":135,"doc_module":4,"doc_module_name":25,"category_name":136,"show_sort_weight":137,"slug":138},6,"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":25,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":97,"slug":145},"research-report",{"id":147,"doc_module":4,"doc_module_name":25,"category_name":148,"show_sort_weight":149,"slug":150},9,"Religion & Spirituality",20,"religion-spirituality",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":152,"show_sort_weight":149,"slug":153},"World Cup","world-cup",{"id":155,"doc_module":4,"doc_module_name":25,"category_name":156,"show_sort_weight":155,"slug":157},10,"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":25,"category_name":160,"show_sort_weight":130,"slug":161},19,"General","general"]